###begin article-title 0
###xml 66 93 66 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis </italic>
###xml 66 92 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Analysis of DNA relaxation and cleavage activities of recombinant Mycobacterium tuberculosis DNA topoisomerase I from a new expression and purification protocol
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 0 27 0 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis </italic>
###xml 347 364 347 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 368 384 368 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 347 363 <span type="species:ncbi:562">Escherichia coli</span>
###xml 368 383 <span type="species:ncbi:1773">M. tuberculosis</span>
Mycobacterium tuberculosis DNA topoisomerase I is an attractive target for discovery of novel TB drugs that act by enhancing the accumulation of the topoisomerase-DNA cleavage product. It shares a common transesterification domain with other type IA DNA topoisomerases. There is, however, no homology between the C-terminal DNA binding domains of Escherichia coli and M. tuberculosis DNA topoisomerase I proteins.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 62 78 62 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 268 276 268 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 62 77 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 268 275 <span type="species:ncbi:562">E. coli</span>
A new protocol for expression and purification of recombinant M. tuberculosis DNA topoisomerase I (MtTOP) has been developed to produce enzyme of much higher specific activity than previously characterized recombinant enzyme. MtTOP was found to be less efficient than E. coli DNA topoisomerase I (EcTOP) in removal of remaining negative supercoils from partially relaxed DNA. DNA cleavage by MtTOP was characterized for the first time. Comparison of DNA cleavage site selectivity with EcTOP showed differences in cleavage site preferences, but the preferred sites of both enzymes have a C nucleotide in the -4 position.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 12 28 12 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 118 126 118 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 182 198 182 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 12 27 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 118 125 <span type="species:ncbi:562">E. coli</span>
###xml 182 197 <span type="species:ncbi:1773">M. tuberculosis</span>
Recombinant M. tuberculosis DNA topoisomerase I can be expressed as a soluble protein and purified in high yield from E. coli host with a new protocol. Analysis of DNA cleavage with M. tuberculosis DNA substrate showed that the preferred DNA cleavage sites have a C nucleotide in the -4 position.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 356 357 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 358 359 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 487 488 487 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 569 570 569 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 852 853 852 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 854 855 854 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
DNA topoisomerases are ubiquitous enzymes involved in the regulation of DNA supercoiling and overcoming topological barriers during replication, transcription, recombination and repair. In bacteria, the major classes of topoisomerases, type IA and type IIA, modify DNA topology by transiently cleaving and rejoining one or two strands of DNA respectively [1,2]. Both of these classes form a 5'-phosphotyrosyl enzyme-DNA linkage during the catalytic cycle of DNA cleavage and religation [1]. Topoisomerases are attractive targets for development of new anti-infectives [3]. Bacterial DNA gyrase and topoisomerase IV from the type IIA class are targets of antibiotics such as quinolones and fluoroquinolones. These antibiotics exhibit their bactericidal properties by trapping the covalent protein-DNA complexes formed by DNA gyrase or topoisomerase IV [4,5]. Although fluoroquinolones are effective against a broad spectrum of bacteria, alarming increase in fluoroquinolone-resistant pathogens warrants the need to develop novel drugs against new cellular targets.
###end p 9
###begin p 10
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 159 176 159 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 744 745 744 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 858 859 858 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1022 1024 1022 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1077 1103 1077 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 1161 1177 1161 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 1215 1216 1215 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 159 175 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1077 1103 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 1161 1176 <span type="species:ncbi:1773">M. tuberculosis</span>
Bacterial topoisomerase I, responsible for relaxing negatively supercoiled DNA, is the most common type IA topoisomerase present in almost all bacteria [6,7]. Escherichia coli topoisomerase I (EcTOP) is the well studied prototype for type IA topoisomerase [8]. EcTOP relaxes negatively supercoiled DNA through a magnesium-dependent, ATP-independent catalytic mechanism. No specific inhibitor for bacterial topoisomerase I, effective at a relevant clinical and physiological concentration, has been identified. Bacterial topoisomerase I, by virtue of its presence in nearly all bacterial genomes, and in view of its association with DNA during the vulnerable stage of cleavage-religation, could be utilized as a target for novel antimicrobials [3]. This strategy could be useful in developing drugs to treat highly fatal bacterial diseases like tuberculosis [9]. The fact that approximately one-third of the world's population is affected by tuberculosis indicates the need to develop effective drugs against this disease [10]. Also, since multiple drug resistance is common in Mycobacterium tuberculosis, it would be significant if a novel antibiotic targeting M. tuberculosis DNA topoisomerase I can be developed [9].
###end p 10
###begin p 11
###xml 61 77 61 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 243 259 243 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 61 76 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 243 258 <span type="species:ncbi:1773">M. tuberculosis</span>
A logical first step towards finding inhibitors selective to M. tuberculosis topoisomerase I is to characterize the DNA modification ability of this enzyme. In this study, we describe a new expression and purification protocol for recombinant M. tuberculosis topoisomerase I capable of producing milligrams of pure protein. We also report the first detailed characterization of this enzyme with respect to its DNA cleavage sites and relaxation activity under different assay conditions.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 31 47 31 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 31 46 <span type="species:ncbi:1773">M. tuberculosis</span>
Expression and purification of M. tuberculosis topoisomerase I
###end title 13
###begin p 14
###xml 21 37 21 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">topA </italic>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 303 319 303 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 336 344 336 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 411 419 411 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 596 598 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 689 705 689 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 709 733 709 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium smegmatis </italic>
###xml 804 808 804 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">topA</italic>
###xml 822 830 822 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 843 845 843 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 941 943 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1040 1048 1040 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1242 1249 1236 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacUV5 </italic>
###xml 21 42 <span type="species:ncbi:83332">M. tuberculosis H37Rv</span>
###xml 303 318 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 336 348 <span type="species:ncbi:511693">E. coli BL21</span>
###xml 350 353 <span type="species:ncbi:511693">DE3</span>
###xml 411 423 <span type="species:ncbi:511693">E. coli BL21</span>
###xml 425 428 <span type="species:ncbi:511693">DE3</span>
###xml 689 704 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 709 732 <span type="species:ncbi:1772">Mycobacterium smegmatis</span>
###xml 822 829 <span type="species:ncbi:562">E. coli</span>
###xml 1040 1047 <span type="species:ncbi:562">E. coli</span>
###xml 1064 1067 <span type="species:ncbi:511693">DE3</span>
###xml 1144 1147 <span type="species:ncbi:511693">DE3</span>
###xml 1425 1428 <span type="species:ncbi:511693">DE3</span>
Genome sequencing of M. tuberculosis H37Rv strain has revealed the presence of topA gene Rv3646c which encodes a DNA topoisomerase I (MtTOP) comprising of 934 amino acids with an estimated molecular weight of 102.3 kDa [11]. Previously, Yang et al [12] have cloned and purified DNA topoisomerase I from M. tuberculosis Erdman strain in E. coli BL21 (DE3). Our efforts to express and purify recombinant MtTOP in E. coli BL21 (DE3) similarly by induction of the T7 promoter were frustrated by the insolubility of the expressed protein. Difficulties have also been encountered by other researchers [13] while trying to use recombinant DNA topoisomerase I gene present in genomic libraries of M. tuberculosis and Mycobacterium smegmatis to complement the temperature dependent deficiency of topoisomerase I (topA) function in E. coli strain AS17 [14]. Difference in codon usage was surmised to be one of the possible reasons behind this result [13]. We overcame these difficulties by expressing MtTOP from a recombinant plasmid pLIC-MTOP in an E. coli Arctic express (DE3)RP strain (Stratgene) at low temperatures (12degreesC). The Arctic express (DE3)RP strain contained a chromosomally integrated T7 RNA polymerase which was expressed from the lacUV5 promoter. Induction of T7 RNA polymerase protein synthesis with IPTG resulted in the expression of the T7 promoter-driven recombinant protein. In addition, the Arctic express (DE3)RP strain expressed cold chaperonin proteins (Cpn10 and CPn60) and extra copies of tRNAs (recognizing arginine and proline codons) that facilitated the expression of recombinant proteins by overcoming issues of protein solubility and codon bias respectively.
###end p 14
###begin p 15
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 401 404 <span type="species:ncbi:12227?0.9375">TEV</span>
Recombinant MtTOP was soluble and initially expressed as a hexa-histidine fusion protein only in the presence of IPTG (Figure 1). Purification of the fusion protein was achieved using nickel affinity chromatography. Subsequent SDS-PAGE analysis (Figure 2A) showed the predominant presence of only the fusion protein with the expected molecular weight. The hexa-histidine fusion tag was cleaved off by TEV protease treatment and MtTOP of high purity was eluted by increasing the potassium chloride gradient from a single-stranded DNA cellulose column (Figure 2B) [15]. The eluted fractions were pooled and dialyzed into storage buffer. Approximately 12 milligrams of purified protein was obtained from 7 L of bacterial culture in LB medium.
###end p 15
###begin p 16
###xml 35 43 35 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 0 72 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of recombinant MtTOP in <italic>E. coli </italic>Arctic express (DE3)RP strain</bold>
###xml 35 42 <span type="species:ncbi:562">E. coli</span>
###xml 59 62 <span type="species:ncbi:511693">DE3</span>
###xml 179 182 <span type="species:ncbi:511693">DE3</span>
Expression of recombinant MtTOP in E. coli Arctic express (DE3)RP strain. SDS PAGE analysis of total cell lysate (lanes 1,3) and soluble cell lysate (lane 2,4) of Arctic express (DE3)RP cells transformed with pLIC-MTOP and induced with 0 mM (lanes 1,2) and 1 mM IPTG (lanes 3,4) at the end of 24 hours of induction in LB at 12degreesC. M: molecular weight standards.
###end p 16
###begin p 17
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SDS PAGE at different stages of MtTOP purification</bold>
###xml 412 415 <span type="species:ncbi:12227?0.9375">TEV</span>
SDS PAGE at different stages of MtTOP purification. A. Wash (lanes 1-4) and elution (lanes 5-9) fractions of fusion protein passed through a Ni-NTA agarose column. Lanes M represents molecular marker and lanes L and F represent the initial load and flow through of the Ni-NTA agarose column before wash and elution. B. Wash fractions (lanes 1-4) and potassium chloride gradient elution fractions (lanes 5-14) of TEV digested fusion protein loaded onto single-strand DNA cellulose column.
###end p 17
###begin title 18
###xml 47 63 47 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 47 62 <span type="species:ncbi:1773">M. tuberculosis</span>
Characterization of DNA relaxation activity of M. tuberculosis topoisomerase I
###end title 18
###begin p 19
###xml 131 138 131 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli </italic>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 632 634 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 868 869 861 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 131 137 <span type="species:ncbi:562">E.coli</span>
DNA relaxation assay was used to characterize the purified MtTOP. We compared the ability of MtTOP with that of similarly purified E.coli topoisomerase I (EcTOP) [16] in relaxing negatively supercoiled DNA by agarose gel electrophoresis. Initial assays evaluated the minimum amount of enzyme (MtTOP or EcTOP) required to bring about complete relaxation of negatively supercoiled DNA under standard conditions (Figure 3). One unit of enzyme was defined as the amount of enzyme required to relax 0.5 mug of negatively supercoiled plasmid DNA in 30 min at 37degreesC. Results indicated that 100 ng of EcTOP and 500 ng of MtTOP (Figure 3A) constitute one unit of enzyme activity. However, at lower concentrations of enzyme, = 12.5 ng, there is no difference between the ability of MtTOP and EcTOP in removing the negative supercoils from the plasmid DNA substrate (Figure 3).
###end p 19
###begin p 20
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Relaxation of negatively supercoiled DNA to determine unit activity</bold>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
Relaxation of negatively supercoiled DNA to determine unit activity. A. 500 ng of negatively supercoiled plasmid DNA was subjected to relaxation as per the conditions in "materials and methods" with the indicated amount of EcTOP and MtTOP. B. DNA relaxation by different amounts of EcTOP and MtTOP was quantitated as percent relaxation for comparison. The percent relaxation was determined by dividing the distance between the negatively supercoiled band (SC); and the weighted center of the partially relaxed band (PR); by the distance between the supercoiled band (SC); and the fully relaxed band (FR). In simple terms, percent relaxation = (SC-PR)/(SC-FR) [18]. The percent relaxation values reported are averages of at least three independent experiments. Error bars denote the standard error of mean.
###end p 20
###begin p 21
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
For a more detailed analysis of the relaxation activity of the purified enzymes, a time course assay with 50 ng each of MtTOP and EcTOP was performed (Figure 4). At the early time points, the rate of removal of the negative supercoils by the two enzymes was similar. However, as the plasmid DNA substrate became partially relaxed, the relaxation activity of MtTOP was less efficient than EcTOP in removing the residual negative supercoils.
###end p 21
###begin p 22
###xml 0 29 0 29 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Time course of DNA relaxation</bold>
Time course of DNA relaxation. A. 50 ng of EcTOP (lanes 1-10) and MtTOP (lanes 11-20) was utilized in a relaxation assay as described in the "materials and methods" section over time course of 0, 10, 20, 30, 45, 60, 75, 90, 120, 180 sec respectively for each enzyme. B. Quantitation of the relaxation time course. The percent relaxation values reported are averages of at least three independent experiments. Error bars denote the standard error of mean.
###end p 22
###begin p 23
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 133 141 133 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 184 186 184 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 338 341 337 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 356 357 355 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 446 449 445 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 515 518 514 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 583 585 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 616 619 615 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 811 814 810 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 822 824 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 841 844 840 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 948 950 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1029 1041 1028 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. smegmatis</italic>
###xml 1057 1060 1056 1059 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 1126 1128 1125 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 133 140 <span type="species:ncbi:562">E. coli</span>
###xml 1029 1041 <span type="species:ncbi:1772">M. smegmatis</span>
It has been a well known fact that Mg2+ ions are required for the relaxation activity of bacterial type IA topoisomerases, including E. coli topoisomerase I [17,18]. We compared the Mg2+dependence of the relaxation activity of EcTOP and MtTOP using two different enzyme concentrations (50 ng or 1 unit in a 20-mul assay) and a range of Mg2+ levels (Figure 5). At a lower enzyme concentration (50 ng), relaxation by EcTOP had a optimal range of Mg2+ concentrations between 2.5 to 7.5 mM while the optimal range of Mg2+ concentrations for MtTOP was slightly higher (5-12.5 mM) (Figure 5B). Similar optimal levels of Mg2+ were found for the relaxation activities of both the EcTOP and MtTOP at higher enzyme concentrations equivalent to one unit of enzyme activity, with no relaxation observed in the absence of Mg2+ (Figure 5A). The optimal Mg2+ concentrations found here for MtTOP are higher than the 1 mM concentration determined in previous work [12]. In other studies involving the characterization of the topoisomerase I from M. smegmatis, the optimal Mg2+ concentration for relaxation activity was found to be about 5 mM [19].
###end p 23
###begin p 24
###xml 12 15 12 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of Mg<sup>2+ </sup>ion concentration on DNA relaxation</bold>
###xml 92 95 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
Effect of Mg2+ ion concentration on DNA relaxation. Effect of different concentrations of Mg2+ ion concentration ranging from 0-20 mM in DNA relaxation assays containing (A) high level, 1 enzyme unit corresponding to 100 ng of EcTOP and 500 ng of MtTOP; or (B) low level (50 ng) of EcTOP or MtTOP. C: control with no enzyme.
###end p 24
###begin title 25
Mapping of DNA cleavage sites using single-stranded DNA substrates
###end title 25
###begin p 26
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 226 245 226 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Micrococcal luteus </italic>
###xml 379 381 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 617 619 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 620 622 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 703 716 677 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. smegmatis </italic>
###xml 840 842 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 843 845 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 889 891 850 852 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 979 987 940 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 998 1014 959 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 1179 1181 1140 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 1189 1190 1150 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1262 1270 1223 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1273 1288 1234 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 1370 1372 1331 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 1380 1381 1341 1342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1561 1563 1509 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1564 1566 1512 1514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1647 1660 1595 1608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. smegmatis </italic>
###xml 703 715 <span type="species:ncbi:1772">M. smegmatis</span>
###xml 979 986 <span type="species:ncbi:562">E. coli</span>
###xml 998 1013 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1262 1269 <span type="species:ncbi:562">E. coli</span>
###xml 1273 1288 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1647 1659 <span type="species:ncbi:1772">M. smegmatis</span>
Although the majority of topoisomerases do not have specific sequence requirements for cleavage sites, many of them show at least a certain degree of non -randomness in cleavage site recognition [6,20]. For example, EcTOP and Micrococcal luteus topoisomerase I cleave the sequence CXXXdownward arrow (downward arrow represents the cleavage site) more preferentially than others [21]. Archeal and bacterial reverse gyrases, which are type IA topoisomerases, also have limited sequence requirements with only the preference of a cytosine or requirement of at least a pyrimidine at the -4 position of the cleavage site [22-24]. Previous studies elucidating the sequence specificity of topoisomerase I from M. smegmatis reported a strong topoisomerase I site (STS), wherein the enzyme recognizes and cleaves the sequence CG/TCTdownward arrowT [25,26]. We utilized different single-stranded 5'-32P labeled DNA substrates ranging from ~200-550 bases in length generated from either an E. coli plasmid or M. tuberculosis genomic DNA to characterize the MtTOP preferred cleavage sites. Results indicate that the DNA cleavage selectivity of MtTOP is very similar to that of EcTOP (Figure 6A, Table 1). The two enzymes share many cleavage sites on DNA derived either from E. coli or M. tuberculosis, but some cleavage sites were preferred by only one of these two enzymes (Figure 6B, Table 1). All of the cleavage sites for both enzymes were found to have a cytosine at the -4 position (CXXXdownward arrow) as previously shown for many bacterial topoisomerase I enzymes [21,27]. There was no specific cleavage sequence recognition for MtTOP as reported for M. smegmatis topoisomerase I.
###end p 26
###begin p 27
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mapping cleavage sites on single-stranded DNA substrate</bold>
###xml 122 127 122 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">topA </italic>
###xml 135 151 135 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 135 150 <span type="species:ncbi:1773">M. tuberculosis</span>
Mapping cleavage sites on single-stranded DNA substrate. A. Single-stranded DNA substrate Mtop (216 bases) amplified from topA gene of M. tuberculosis was utilized to map cleavage sites of EcTOP and MtTOP. Lanes 1-4: cleavage reactions containing 400, 300, 200, 100 ng of EcTOP respectively. Similarly lanes 5-8 contain 400, 300, 200, 100 ng of MtTOP respectively. B. Single-stranded DNA substrate PBAD (556 bases) amplified from pBAD/thio plasmid was utilized to map cleavage sites of EcTOP and MtTOP. Lanes 1-2: cleavage reactions containing 400, 300 ng of EcTOP respectively. Similarly lanes 3-4 contain 400, 300 ng of MtTOP respectively. Lanes A, G, C, T containing the sequencing reactions with the corresponding nucleotide termination mixes were electrophoresed along with EcTOP and MtTOP cleavage reactions to determine the cleavage sites.
###end p 27
###begin p 28
List of mapped DNA cleavage sites
###end p 28
###begin p 29
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
a Sequences are numbered from -6 to 6 (5' to 3'). Topoisomerase I mediated cleavage occurs between -1 and 1.
###end p 29
###begin p 30
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
b Among sequences cleaved by both EcTOP and MtTOP, sequences showing at least one-fold higher cleavage intensity towards EcTOP or MtTOP than the other enzyme are grouped as EcTOP or MtTOP preferred sequences respectively
###end p 30
###begin title 31
Discussion
###end title 31
###begin p 32
###xml 155 171 155 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 251 267 251 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 369 384 369 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 472 493 472 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis topA </italic>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1200 1208 1200 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 116 119 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 155 170 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 251 266 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 369 384 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 472 487 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1200 1207 <span type="species:ncbi:562">E. coli</span>
###xml 1226 1229 <span type="species:ncbi:511693">DE3</span>
Tuberculosis (TB) is the second leading cause of adult deaths due to infectious diseases world-wide, second only to HIV. The surge in multi-drug resistant M. tuberculosis makes it crucial to identify novel targets for development of new TB treatment. M. tuberculosis topoisomerase I could be one such novel target since there is only one type IA topoisomerase found in M. tuberculosis. A recent genome wide transposon mutagenesis experiment has postulated and categorised M. tuberculosis topA gene as essential [28]. It is also likely to be essential because every bacterium has at least one type IA topoisomerase activity. MtTOP is therefore an attractive target for drugs which would interfere with its relaxation activity (catalytic inhibitors). Moreover, besides inhibiting the overall relaxation activity of MtTOP, a more potent bactericidal effect could be achieved by drugs (catalytic poisons) that enhance the accumulation of covalent complexes on DNA, similar to the bactericidal mechanism of fluoroquinolones on type IIA bacterial topoisomerases. To aide such drug development efforts, it is important to have MtTOP protein in high purity and quantity. Here we report that by utilizing the E. coli Arctic express RP(DE3) strain, we took advantage of the higher GC rich codon usage efficiency and low temperature chaperone in this strain to obtain soluble MtTOP in high yield (12 mg from 7 L of bacterial culture). This enables future development of high through-put assays for inhibitors targeting MtTOP.
###end p 32
###begin p 33
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 226 234 226 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 384 391 384 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 766 768 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 226 233 <span type="species:ncbi:562">E. coli</span>
###xml 384 391 <span type="species:ncbi:562">E. coli</span>
The DNA cleavage activity of MtTOP has not been characterized previously and there is a also a need for more detailed analysis of its DNA relaxation activity than in the early study of the enzyme [12]. Careful comparison with E. coli topoisomerase I (EcTOP) showed that the two enzymes had similar efficiency initially in relaxing the negatively supercoiled plasmid DNA isolated from E. coli. However, as the substrate plasmid DNA became partially relaxed, MtTOP was slower than EcTOP in removing the residual negative supercoils. This could be due to the different C-terminal domain found in the enzymes. The C-terminal domain found in EcTOP has been proposed to be important for substrate binding and coordination of strand passage during the relaxation cycle [29,30]. The C-terminal domain of MtTOP has no homology to the C-terminal domain in EcTOP, so it may function differently during the catalytic cycle. The N-terminal two-thirds, the transesterification domains of EcTOP and MtTOP have high degree of homology (41.9% identical).
###end p 33
###begin p 34
###xml 35 43 35 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 47 63 47 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 396 409 396 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. smegmatis </italic>
###xml 562 564 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 565 567 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 578 591 565 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. smegmatis </italic>
###xml 761 769 735 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 788 790 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 842 844 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 894 896 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 35 42 <span type="species:ncbi:562">E. coli</span>
###xml 47 62 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 396 408 <span type="species:ncbi:1772">M. smegmatis</span>
###xml 578 590 <span type="species:ncbi:1772">M. smegmatis</span>
###xml 761 768 <span type="species:ncbi:562">E. coli</span>
###xml 817 822 <span type="species:ncbi:9606">human</span>
###xml 869 874 <span type="species:ncbi:4932">yeast</span>
Analysis of cleavage sites on both E. coli and M. tuberculosis derived DNA substrate showed that the cleavage site preferences are quite similar with a C in the -4 position as have been observed for several bacterial topoisomerase I as well as archeal and bacterial reverse gyrase enzymes. It is somewhat surprising that the cleavage site preference of MtTOP is not the same as that reported for M. smegmatis topoisomerase I (CG/TCTdownward arrowT). It is possible that this is due to the different experimental protocols used in analysis of the cleavage sites [25,26]. Besides M. smegmatis topoisomerase I, there are other examples of type IA topoisomerases that have cleavage site preferences different from that of EcTOP. These include CTTdownward arrow for E. coli topoisomerase III [31], CANNNdownward arrow for human topoisomerase III [32], ANNdownward arrow for yeast topoisomerase III [33]. It remains unclear which part of the type IA enzyme structure determines the cleavage site selectivity. The specific sequence information for DNA cleavage by MtTOP should be useful in design of oligonucleotide substrates for DNA cleavage assays.
###end p 34
###begin title 35
Conclusion
###end title 35
###begin p 36
A new procedure for expression and purification of recombinant MtTOP protein in high yield has been described. The enzyme is as efficient as EcTOP in initial removal of negative supercoils from plasmid DNA, but is less efficient than EcTOP in removing the remaining negative supercoils. The preferred DNA cleavage sites of MtTOP have limited sequence specificity but contain a C nucleotide in the -4 position, similar to most bacterial topoisomerase I and archeal reverse gyrase cleavage sites characterized previously.
###end p 36
###begin title 37
Methods
###end title 37
###begin title 38
MtTOP expression and purification
###end title 38
###begin p 39
###xml 60 67 60 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli </italic>
###xml 171 187 171 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis </italic>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 689 691 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 789 797 789 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1173 1175 1167 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1203 1204 1197 1198 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1206 1207 1200 1201 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1447 1448 1441 1442 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1450 1451 1444 1445 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1562 1563 1556 1557 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1565 1566 1559 1560 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1826 1828 1820 1822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 60 66 <span type="species:ncbi:562">E.coli</span>
###xml 83 86 <span type="species:ncbi:511693">DE3</span>
###xml 171 186 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 615 633 <span type="species:ncbi:12227">tobacco etch virus</span>
###xml 635 638 <span type="species:ncbi:12227?0.9375">TEV</span>
###xml 789 796 <span type="species:ncbi:562">E. coli</span>
###xml 887 890 <span type="species:ncbi:511693">DE3</span>
###xml 980 983 <span type="species:ncbi:511693">DE3</span>
###xml 1684 1687 <span type="species:ncbi:12227?0.9375">TEV</span>
MtTOP was expressed from a recombinant plasmid pLIC-MTOP in E.coli Arctic express (DE3)RP strain (Stratagene). MtTOP coding sequence was amplified from the genomic DNA of M. tuberculosis H37RV strain with suitable primers (LIC-Mtop5'-TACTTCCAATCCAATGCAGCTGACCCGAAAACG and LIC-Mtop3'-TTATCCACTTCCAATGTTATTAGTCGCGCTTGGCTGC) using PfuUltra II Fusion HS DNA polymerase (Stratagene) and cloned into a vector pLIC-HK [34] through a ligation independent cloning procedure [35]. Cloning of MtTOP coding sequence into this vector containing a T7 promoter allowed T7 RNA polymerase dependent expression of MtTOP along with a tobacco etch virus (TEV) protease-cleavable N-terminal hexahistidine tag [34]. The resulting pLIC-MTOP plasmid, capable of expressing recombinant MtTOP was first isolated in E. coli NEB Turbo competent cells (New England Biolabs) and then transformed into Arctic express (DE3)RP cells after sequence confirmation. Expression of MtTOP in transformed Arctic express (DE3)RP cells was induced by 1 mM IPTG at 12degreesC according to the manufacturer's (Stratagene) protocol. After 24 h of induction, the cells were collected and subjected to freeze-thaw lysis [15] in lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, 1 mg/ml Lysozyme, pH 8.0). The recombinant protein in the soluble lysate was allowed to bind to Ni-NTA agarose (Qiagen) and packed into a column. After washing the column overnight with wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0), the topoisomerase protein was eluted with an elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM Imidazole, pH 8.0) containing higher concentrations of imidazole. Eluted MtTOP was cleaved with TEV protease to remove the N-terminal hexa-histidine tag and purified by passing through a single-stranded DNA cellulose column as described [15].
###end p 39
###begin title 40
DNA Relaxation Activity assays
###end title 40
###begin p 41
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 297 299 296 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
To assay for one unit of relaxation activity, EcTOP [16] and MtTOP enzymes of the same concentrations were diluted serially, ranging from 500-1 ng and assayed for DNA relaxation activity in a standard reaction volume of 20 mul with 10 mM Tris-HCl (pH 8.0), 50 mM NaCl, 0.1 mg/ml gelatin, 6 mM MgCl2 and 0.5 mug of supercoiled pBAD/thio plasmid DNA (purified by CsCl gradient centrifugation). After incubation at 37degreesC for 30 min, the reactions were stopped by adding 5 ul of 50 mM EDTA, 50% glycerol and 0.5%(v/v) bromophenol blue. The DNA was electrophoresed in a 1.0% (w/v) agarose gel with TAE buffer (40 mM Tris-acetate, pH 8.1, 2 mM EDTA). The gel was stained with ethidium bromide and photographed over UV light. One unit of enzyme was defined as the least quantity of the enzyme required for complete relaxation of negatively supercoiled DNA under the given reaction conditions.
###end p 41
###begin p 42
###xml 2 5 2 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 195 197 195 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 403 404 397 398 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Mg2+ dependence of EcTOP and MtTOP to relax negatively supercoiled DNA was compared with either 50 ng or one unit of enzyme (100 ng of EcTOP, 500 ng of MtTOP) under varying concentrations of MgCl2 ranging from 0-20 mM over a time period of 30 min at 37degreesC with similar reaction conditions as described above. Also, a low concentration (50 ng) of EcTOP and MtTOP under standard conditions (6 mM MgCl2) as described earlier was used to compare the ability of the respective enzymes to relax negatively supercoiled DNA at various time points of 0, 10, 20, 30, 45, 60, 75, 90, 120 and 180 sec at 37degreesC.
###end p 42
###begin title 43
Cleavage of Single-stranded DNA
###end title 43
###begin p 44
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 301 303 297 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
To compare and map the cleavage sites of EcTOP and MtTOP, single stranded DNA substrates were generated first by PCR (Table 2), followed by strand denaturation. Each of these substrates were radio-labeled at the 5' end by having one of the corresponding forward or reverse primers labeled with [gamma-32P]ATP in the presence of T4 polynucleotide kinase prior to the PCR. The PCR products were purified using the DNA Clean and Concentrator Kit (Zymos) and eluted in TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA). Prior to the addition of topoisomerase in the cleavage assay, the DNA substrate was denatured to single strands by heating at 95degreesC for 5 min and rapidly cooled on ice. After incubation with the topoisomerase at 37degreesC for 10 min, trapping of the covalent enzyme-DNA complex and cleaved DNA was achieved by the addition of 0.1 M NaOH. After neutralization, the DNA was electrophoresed in a 6% polyacrylamide sequencing gel followed by autoradiography of the dried gel to visualize the 5'-end-labeled DNA cleavage products. DNA sequencing reaction products were generated with the same 5' end labeled primer corresponding to that of the substrate used in the cleavage assay and by following the cycle sequencing procedures according to the manufacturer's instructions (SequiTherm DNA sequencing Kit, Epicentre). The sequencing reaction products were electrophoresed next to lanes containing cleavage products to identify the cleavage sites.
###end p 44
###begin p 45
Single stranded DNA substrates used
###end p 45
###begin p 46
###xml 9 11 9 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
* Primer 32P labeled at 5'end to analyze extended strand as cleavage substrate after denaturation of the PCR product. The left and right primers of MdnaK were utilized in separate experiments.
###end p 46
###begin title 47
Authors' contributions
###end title 47
###begin p 48
AA carried out the relaxation and DNA cleavage assays, and drafted the manuscript. ND and BC developed and carried out the expression and purification protocol. YT conceived the study, and participated in the design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 48
###begin title 49
Acknowledgements
###end title 49
###begin p 50
###xml 50 53 <span type="species:ncbi:12227?0.9375">TEV</span>
We wish to thank Elena Sorokin for preparation of TEV protease. This research was supported by a grant from the National Institutes of Health (R01-GM54226) to YT.
###end p 50
###begin article-title 51
Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases
###end article-title 51
###begin article-title 52
Cellular roles of DNA topoisomerases: a molecular perspective
###end article-title 52
###begin article-title 53
Exploring DNA Topoisomerases as Targets of Novel Therapeutic Agents in the Treatment of Infectious Diseases
###end article-title 53
###begin article-title 54
Mechanism of fluoroquinolone action
###end article-title 54
###begin article-title 55
Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase resistance
###end article-title 55
###begin article-title 56
DNA topoisomerases: structure, function, and mechanism
###end article-title 56
###begin article-title 57
Origin and evolution of DNA topoisomerases
###end article-title 57
###begin article-title 58
Bacterial and archeal type I topoisomerases
###end article-title 58
###begin article-title 59
DNA topoisomerase I from mycobacteria-a potential drug target
###end article-title 59
###begin article-title 60
World Health Organization: Tuberculosis fact sheet
###end article-title 60
###begin article-title 61
###xml 27 53 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
###end article-title 61
###begin article-title 62
###xml 81 107 81 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 81 107 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Cloning, expression, purification and characterization of DNA topoisomerase I of Mycobacterium tuberculosis
###end article-title 62
###begin article-title 63
###xml 24 78 24 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis and Mycobacterium smegmatis</italic>
###xml 24 50 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 55 78 <span type="species:ncbi:1772">Mycobacterium smegmatis</span>
DNA topoisomerases from Mycobacterium tuberculosis and Mycobacterium smegmatis
###end article-title 63
###begin article-title 64
###xml 55 72 55 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 55 71 <span type="species:ncbi:562">Escherichia coli</span>
Probing the structural domains and function in vivo of Escherichia coli DNA topoisomerase I by mutagenesis
###end article-title 64
###begin article-title 65
Overexpression and purification of bacterial DNA topoisomerase I
###end article-title 65
###begin article-title 66
###xml 16 19 16 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
Inhibition of Mg2+ binding and DNA religation by bacterial topoisomerase I via introduction of an additional positive charge into the active site region
###end article-title 66
###begin article-title 67
###xml 31 48 31 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 31 47 <span type="species:ncbi:562">Escherichia coli</span>
Interaction between DNA and an Escherichia coli protein omega
###end article-title 67
###begin article-title 68
###xml 23 31 23 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 23 30 <span type="species:ncbi:562">E. coli</span>
Mechanistic studies on E. coli DNA topoisomerase I: divalent ion effects
###end article-title 68
###begin article-title 69
###xml 25 48 25 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium smegmatis</italic>
###xml 25 48 <span type="species:ncbi:1772">Mycobacterium smegmatis</span>
DNA topoisomerase I from Mycobacterium smegmatis
###end article-title 69
###begin article-title 70
DNA topoisomerases
###end article-title 70
###begin article-title 71
Covalent bonds between protein and DNA. Formation of phosphotyrosine linkage between certain DNA topoisomerases and DNA
###end article-title 71
###begin article-title 72
Archaebacterial reverse gyrase cleavage-site specificity is similar to that of eubacterial DNA topoisomerases I
###end article-title 72
###begin article-title 73
###xml 48 68 48 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sulfolobus shibatae </italic>
###xml 48 71 <span type="species:ncbi:523848">Sulfolobus shibatae B12</span>
Analysis of DNA cleavage by reverse gyrase from Sulfolobus shibatae B12
###end article-title 73
###begin article-title 74
###xml 51 71 51 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Thermotoga maritime </italic>
Mutational analysis of the helicase-like domain of Thermotoga maritime reverse gyrase
###end article-title 74
###begin article-title 75
###xml 25 48 25 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium smegmatis</italic>
###xml 25 48 <span type="species:ncbi:1772">Mycobacterium smegmatis</span>
DNA topoisomerase I from Mycobacterium smegmatis. An enzyme with distinct features
###end article-title 75
###begin article-title 76
###xml 45 69 45 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium smegmatis </italic>
###xml 45 68 <span type="species:ncbi:1772">Mycobacterium smegmatis</span>
Determination of the recognition sequence of Mycobacterium smegmatis topoisomerase I on mycobacterial genomic sequences
###end article-title 76
###begin article-title 77
###xml 39 58 39 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Thermotoga maritima</italic>
###xml 39 58 <span type="species:ncbi:2336">Thermotoga maritima</span>
Hyperthermophilic topoisomerase I from Thermotoga maritima. A very efficient enzyme that functions independently of zinc binding
###end article-title 77
###begin article-title 78
Genetic requirements for mycobacterial survival during infection
###end article-title 78
###begin article-title 79
###xml 32 49 32 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 32 48 <span type="species:ncbi:562">Escherichia coli</span>
The carboxyl terminal domain of Escherichia coli DNA topoisomerase I confers higher affinity to DNA
###end article-title 79
###begin article-title 80
###xml 58 65 <span type="species:ncbi:562">E. coli</span>
The role of the Zn(II) binding domain in the mechanism of E. coli DNA topoisomerase I
###end article-title 80
###begin article-title 81
###xml 34 51 34 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 34 50 <span type="species:ncbi:562">Escherichia coli</span>
The carboxyl-terminal residues of Escherichia coli DNA topoisomerase III are involved in substrate binding
###end article-title 81
###begin article-title 82
###xml 37 42 <span type="species:ncbi:9606">human</span>
Purification and characterization of human DNA topoisomerase IIIalpha
###end article-title 82
###begin article-title 83
###xml 22 27 <span type="species:ncbi:4932">yeast</span>
Identification of the yeast TOP3 gene product as a single strand-specific DNA topoisomerase
###end article-title 83
###begin article-title 84
Crosstalk between primase subunits can act to regulate primer synthesis in trans
###end article-title 84
###begin article-title 85
High-throughput cloning for proteomics research
###end article-title 85

